Therapeutic Glypican‐3 CRISPR Genome‐Editing Using UltraLarge Porous Silica Nano‐Depot for the Treatment of Hepatocellular Carcinoma
Glypican‐3 (GPC3) is a key diagnostic marker and therapeutic target in hepatocellular
carcinoma (HCC), interacting with Wnt and Hippo/YAP pathways related to cancer …
carcinoma (HCC), interacting with Wnt and Hippo/YAP pathways related to cancer …